Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Foundation Medicine Inc (NASDAQ:FMI)

During the Trading Day
13.71 -0.15 / -1.08%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
13.79 +0.0778 / +0.57%
 
Volume: 2.1K
No recent news for Foundation Medicine Inc.

Today’s Trading

Previous close13.86
Today’s open13.59
Day’s range13.49 - 14.42
Volume157,494
Average volume (3 months)306,821
Market cap$477.5M
Dividend yield--
Data as of 4:00pm ET, 02/09/2016

Growth & Valuation

Earnings growth (last year)+59.70%
Earnings growth (this year)-45.28%
Earnings growth (next 5 years)--
Revenue growth (last year)+110.69%
P/E ratioNM
Price/Sales10.17
Price/Book4.54

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...+0.17+1.36%
ATRAAtara Biotherapeutic...+0.09+0.57%
ADAPAdaptimmune Therapeu...-0.63-8.81%
RTRXRetrophin Inc-0.42-2.97%
Data as of 4:00pm ET, 02/09/2016

Financials

Next reporting dateFebruary 23, 2016
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$61.1M
Annual profit (last year)-$52.2M
Net profit margin-85.50%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michael J. Pellini
President &
Chief Operating Officer
Steven J. Kafka
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers